Don't see why they would be financing cash flows. There is no financing happening here.
I read Notes 1 and 8 of the FY17 Annual Report to be that Receipts form Customers includes the amount held in trust for remittances. Reconciliation of Revenue from Sales (ex R&D grant) (~$2.2M) to Cash Receipts From Customers (~$5.9M) seems confirm. And there is not significant movement in related balance sheet accounts to address the difference.
Which I assume is why their December commentary has not reference to $8M (+$4M) receipts, but talks about revenue but growth to $339k (transactional)
Anyway, interested to see the half yearly which will will confirm.
Don't see why they would be financing cash flows. There is no...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13383 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 51593 | 1 |
View Market Depth
| Last trade - 10.18am 27/11/2024 (20 minute delay) ? |
| NOV (ASX) Chart |
Day chart unavailable
